White label ELPA - ClinicalTrials.eu

Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
+1
A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

Recruiting

1 1 1
Investigated diseases:
A study comparing furazidin and clindamycin for women with bacterial vaginosis

Recruiting

3 1 1 1
Investigated diseases:
- Bacterial vaginosis
Investigated drugs:
- Clindamycin Phosphate
A study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans

Recruiting

2 1
Investigated diseases:
- Progressive multiple sclerosis
Investigated drugs:
- ACT-1004-1239
Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

Recruiting

3 1
Investigated drugs:
- Glepaglutide
+8
A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

Recruiting

4 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Pembrolizumab
+5
Study of inavolisib and fulvestrant for patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Recruiting

2 1 1 1
Investigated diseases:
- Breast cancer metastatic
- Breast cancer
Investigated drugs:
- Fulvestrant
- Inavolisib
A Study of CND261 for Patients with Active ANCA-Positive Vasculitis That Has Not Responded to Previous Treatments

Recruiting

1 1 1
Investigated diseases:
- Anti-neutrophil cytoplasmic antibody positive vasculitis
Testing 18F-DPA-714 PET scan as a marker of brain inflammation in patients with autoimmune encephalitis

Recruiting

2 1 1
Investigated diseases:
- Encephalitis autoimmune
Study of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy

Recruiting

2 1
Investigated diseases:
- Cerebral palsy
Investigated drugs:
- Cenegermin

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies